Drug Price Competition and Patent Term Restoration Act of 1984

Target entity: Drug Price Competition and Patent Term Restoration Act of 1984
Context triple: [Federal Food, Drug, and Cosmetic Act, amendedBy, Drug Price Competition and Patent Term Restoration Act of 1984]

• A. False Claims Amendments Act of 1986
  The False Claims Amendments Act of 1986 is a major U.S. federal law that strengthened the government’s ability to combat fraud against federal programs by expanding whistleblower (qui tam) provisions and increasing penalties for false claims.
• B. Anti-Drug Abuse Act of 1988
  The Anti-Drug Abuse Act of 1988 is a U.S. federal law that expanded the war on drugs by increasing penalties, funding enforcement and treatment programs, and establishing a coordinated national drug control strategy.
• C. Anti-Drug Abuse Act of 1986
  The Anti-Drug Abuse Act of 1986 is a major U.S. federal law that significantly escalated the War on Drugs by establishing mandatory minimum sentences and harsher penalties for drug offenses, particularly involving crack cocaine.
• D. Patent and Trademark Law Amendments Act
  The Patent and Trademark Law Amendments Act, commonly known as the Bayh–Dole Act, is a U.S. federal law that allows universities, small businesses, and non-profits to retain ownership of inventions developed with federal funding, thereby promoting commercialization of research.
• E. Bayh–Dole Act
  The Bayh–Dole Act is a landmark 1980 U.S. law that allows universities, small businesses, and other institutions to retain ownership of inventions developed with federal funding, spurring technology transfer and commercialization.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: Drug Price Competition and Patent Term Restoration Act of 1984
Target entity description: The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.

• A. False Claims Amendments Act of 1986
  The False Claims Amendments Act of 1986 is a major U.S. federal law that strengthened the government’s ability to combat fraud against federal programs by expanding whistleblower (qui tam) provisions and increasing penalties for false claims.
• B. Anti-Drug Abuse Act of 1988
  The Anti-Drug Abuse Act of 1988 is a U.S. federal law that expanded the war on drugs by increasing penalties, funding enforcement and treatment programs, and establishing a coordinated national drug control strategy.
• C. Anti-Drug Abuse Act of 1986
  The Anti-Drug Abuse Act of 1986 is a major U.S. federal law that significantly escalated the War on Drugs by establishing mandatory minimum sentences and harsher penalties for drug offenses, particularly involving crack cocaine.
• D. Patent and Trademark Law Amendments Act
  The Patent and Trademark Law Amendments Act, commonly known as the Bayh–Dole Act, is a U.S. federal law that allows universities, small businesses, and non-profits to retain ownership of inventions developed with federal funding, thereby promoting commercialization of research.
• E. Bayh–Dole Act
  The Bayh–Dole Act is a landmark 1980 U.S. law that allows universities, small businesses, and other institutions to retain ownership of inventions developed with federal funding, spurring technology transfer and commercialization.
• F. None of above. chosen